Cell Panel Screening Services for Immuno-Oncology Drug Discovery
At Creative Biolabs, we offer state-of-the-art cell panel screening services designed to accelerate the discovery and development of innovative cancer therapies. Our services encompass comprehensive screening panels, target-specific panels, and custom cancer cell panels, tailored to meet the intricate needs of modern drug discovery.
Target-Specific Panels
At Creative Biolabs, we have established comprehensive cell panels consisting of 170 diverse cancer cell lines. These cell lines encompass a wide array of tumor types and genetic backgrounds, offering a well-rounded platform for assessing drug efficacy across multiple contexts. By employing our screening panels, researchers can identify potential leads early in the drug development process, thereby streamlining the path to therapeutic innovation.
RAS-Related Panels
Featuring cell lines focused on KRAS and NRAS mutations. These panels, available in both 2D and 3D assay formats, cover major mutations such as KRAS G12C, G12V, G12D, and NRAS mutations, offering insights into mutation-specific drug effects and drug resistance profiling.
-
20 or 40 cell lines
-
5-15 cancer types
DNA Damage Response (DDR) Panels
Our DDR panels focus on DNA damage response pathways, with up to 65 cell lines characterized by critical mutations such as BRCA and TP53. These panels, adaptable for both monotherapy and combination therapy validation, provide a comprehensive approach to tackling tumors with defective DNA repair mechanisms.
View DDR Panels →
WRN Panels
Focused on Werner syndrome-related mutations, these panels target WRN and include a selection of tumor cells with varying microsatellite statuses, allowing flexible analysis adaptable to specific research needs.
-
30 or 50 cell lines targeting WRN
PARP1/2 Panels
Focused on 30 or 50 cell lines to explore PARP1/2-related genes, these panels enable comprehensive validation methods using engineered and drug-resistant cells.
-
30 or 50 cell lines targeting PARP1/2
Custom Cell Panels
To meet the specific demands of personalized medicine and unique research goals, our lab offers more than 500 human tumor cell lines used for cell panel screening services. These cell lines cover over 30 types of cancer, including common types such as lung cancer, lymphoma, gastric cancer, breast cancer, prostate cancer, and colon cancer. Our tailored panels such as the custom breast cancer cell panel and the custom colorectal cancer cell panel, enable researchers to select from an extensive range of cell lines. By selecting from over 50 breast cancer cell lines and 40 colorectal cancer cell lines, including various subtypes, researchers can design personalized panels that closely align with their specific research goals.
Advantages
-
Extensive Cell Line Coverage
We offer over 500 human tumor cell lines covering 30+ cancer types, enabling broad-spectrum screening and supporting diverse oncology research needs.
-
Targeted Mutation Focus
Specialized panels for KRAS, NRAS, BRCA, TP53, WRN, and PARP1/2 allow precise evaluation of mutation-specific drug effects and resistance mechanisms.
-
Flexible Assay Formats
Available in both 2D and 3D models, our assays support more physiologically relevant analysis, enhancing the predictive value of preclinical data.
-
Customizable Panel Design
Researchers can create custom panels from 50+ breast and 40+ colorectal cancer cell lines, tailored to specific cancer subtypes and study goals.
-
Accelerated Drug Discovery
By integrating diverse genetic backgrounds and mutation profiles, our panels streamline early lead identification and reduce time-to-candidate.
For more information on how our cell panel screening services accelerate your research and development efforts, please contact our team of experts, who are ready to collaborate on your journey toward therapeutic innovation.
For Research Use Only | Not For Clinical Use
Download our brochure
